772 related articles for article (PubMed ID: 12815096)
1. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects.
Ortiz LA; Gambelli F; McBride C; Gaupp D; Baddoo M; Kaminski N; Phinney DG
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8407-11. PubMed ID: 12815096
[TBL] [Abstract][Full Text] [Related]
2. Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice.
Ortiz LA; Lasky J; Hamilton RF; Holian A; Hoyle GW; Banks W; Peschon JJ; Brody AR; Lungarella G; Friedman M
Exp Lung Res; 1998; 24(6):721-43. PubMed ID: 9839161
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis.
Tashiro J; Elliot SJ; Gerth DJ; Xia X; Pereira-Simon S; Choi R; Catanuto P; Shahzeidi S; Toonkel RL; Shah RH; El Salem F; Glassberg MK
Transl Res; 2015 Dec; 166(6):554-67. PubMed ID: 26432923
[TBL] [Abstract][Full Text] [Related]
4. Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis.
Takao S; Nakashima T; Masuda T; Namba M; Sakamoto S; Yamaguchi K; Horimasu Y; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Takahashi S; Nakashima A; Hattori N
Stem Cell Res Ther; 2021 Sep; 12(1):506. PubMed ID: 34530920
[TBL] [Abstract][Full Text] [Related]
5. Human placental mesenchymal stem cells of fetal origins-alleviated inflammation and fibrosis by attenuating MyD88 signaling in bleomycin-induced pulmonary fibrosis mice.
Li F; Han F; Li H; Zhang J; Qiao X; Shi J; Yang L; Dong J; Luo M; Wei J; Liu X
Mol Immunol; 2017 Oct; 90():11-21. PubMed ID: 28662409
[TBL] [Abstract][Full Text] [Related]
6. Bleomycin-induced pulmonary fibrosis is independent of eosinophils.
Hao H; Cohen DA; Jennings CD; Bryson JS; Kaplan AM
J Leukoc Biol; 2000 Oct; 68(4):515-21. PubMed ID: 11037973
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis.
Lan YW; Choo KB; Chen CM; Hung TH; Chen YB; Hsieh CH; Kuo HP; Chong KY
Stem Cell Res Ther; 2015 May; 6(1):97. PubMed ID: 25986930
[TBL] [Abstract][Full Text] [Related]
8. Grape seed extract ameliorates bleomycin-induced mouse pulmonary fibrosis.
Liu Q; Jiang JX; Liu YN; Ge LT; Guan Y; Zhao W; Jia YL; Dong XW; Sun Y; Xie QM
Toxicol Lett; 2017 May; 273():1-9. PubMed ID: 28300665
[TBL] [Abstract][Full Text] [Related]
9. Plasma and pulmonary pharmacokinetics of bleomycin in murine strains that are sensitive and resistant to bleomycin-induced pulmonary fibrosis.
Harrison JH; Lazo JS
J Pharmacol Exp Ther; 1988 Dec; 247(3):1052-8. PubMed ID: 2462625
[TBL] [Abstract][Full Text] [Related]
10. NMDA receptor activation inhibits the antifibrotic effect of BM-MSCs on bleomycin-induced pulmonary fibrosis.
Li X; Li C; Tang Y; Huang Y; Cheng Q; Huang X; Zhao F; Hao C; Feng D; Xu J; Han J; Tang S; Liu W; Yue S; Luo Z
Am J Physiol Lung Cell Mol Physiol; 2018 Sep; 315(3):L404-L421. PubMed ID: 29722562
[TBL] [Abstract][Full Text] [Related]
11. Acute pulmonary toxicity of bleomycin: DNA scission and matrix protein mRNA levels in bleomycin-sensitive and -resistant strains of mice.
Harrison JH; Hoyt DG; Lazo JS
Mol Pharmacol; 1989 Aug; 36(2):231-8. PubMed ID: 2475758
[TBL] [Abstract][Full Text] [Related]
12. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.
Yasui H; Gabazza EC; Tamaki S; Kobayashi T; Hataji O; Yuda H; Shimizu S; Suzuki K; Adachi Y; Taguchi O
Am J Respir Crit Care Med; 2001 Jun; 163(7):1660-8. PubMed ID: 11401891
[TBL] [Abstract][Full Text] [Related]
13. Cyclophosphamide Combined with Bone Marrow Mesenchymal Stromal Cells Protects against Bleomycin-induced Lung Fibrosis in Mice.
Xu J; Li L; Xiong J; Zheng Y; Ye Q; Li Y
Ann Clin Lab Sci; 2015; 45(3):292-300. PubMed ID: 26116593
[TBL] [Abstract][Full Text] [Related]
14. Secretoglobin 3A2 Exhibits Anti-Fibrotic Activity in Bleomycin-Induced Pulmonary Fibrosis Model Mice.
Cai Y; Kimura S
PLoS One; 2015; 10(11):e0142497. PubMed ID: 26559674
[TBL] [Abstract][Full Text] [Related]
15. Anti-fibrotic effects of different sources of MSC in bleomycin-induced lung fibrosis in C57BL6 male mice.
Periera-Simon S; Xia X; Catanuto P; Coronado R; Kurtzberg J; Bellio M; Lee YS; Khan A; Smith R; Elliot SJ; Glassberg MK
Respirology; 2021 Feb; 26(2):161-170. PubMed ID: 32851725
[TBL] [Abstract][Full Text] [Related]
16. Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice.
Fang B; Shi M; Liao L; Yang S; Liu Y; Zhao RC
Transplantation; 2004 Jul; 78(1):83-8. PubMed ID: 15257043
[TBL] [Abstract][Full Text] [Related]
17. Metformin Reduces Bleomycin-induced Pulmonary Fibrosis in Mice.
Choi SM; Jang AH; Kim H; Lee KH; Kim YW
J Korean Med Sci; 2016 Sep; 31(9):1419-25. PubMed ID: 27510385
[TBL] [Abstract][Full Text] [Related]
18. Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly.
Chu KA; Wang SY; Yeh CC; Fu TW; Fu YY; Ko TL; Chiu MM; Chen TH; Tsai PJ; Fu YS
Theranostics; 2019; 9(22):6646-6664. PubMed ID: 31588241
[TBL] [Abstract][Full Text] [Related]
19. T cell independence of bleomycin-induced pulmonary fibrosis.
Helene M; Lake-Bullock V; Zhu J; Hao H; Cohen DA; Kaplan AM
J Leukoc Biol; 1999 Feb; 65(2):187-95. PubMed ID: 10088601
[TBL] [Abstract][Full Text] [Related]
20. Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis.
Takahashi F; Takahashi K; Okazaki T; Maeda K; Ienaga H; Maeda M; Kon S; Uede T; Fukuchi Y
Am J Respir Cell Mol Biol; 2001 Mar; 24(3):264-71. PubMed ID: 11245625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
